Table 1.
Focus group participant characteristics
| Overall (n=93) | Boston (n=33) | Detroit (n=19) | Dallas (n=20) | Oklahoma City (n=21) | |
|---|---|---|---|---|---|
| Mean age (n=91) | 54 (sd=11.2) | 50 (sd=11.5) | 59 (sd=10.2) | 56 (sd=10.7) | 54 (sd=10.5) |
| Male | 38 (41%) | 16 (49%) | 8 (42%) | 7 (25%) | 7 (33%) |
| Race | |||||
| White | 61 (66%) | 23 (70%) | 10 (53%) | 13 (65%) | 15 (71%) |
| African American | 21 (23%) | 5 (15%) | 9 (47%) | 6 (30%) | 1 (5%) |
| Other | 7 (8%) | 3 (9%) | 0 | 1 (5%) | 3 (14%) |
| Unknown | 4 (4%) | 2 (6%) | 0 | 0 | 2 (10%) |
| Hispanic/Latino | 5 (5%) | 2 (6%) | 0 | 2 (10%) | 1 (5%) |
| Uninsured during the 12 months prior to the FG | 19 (20%) | 5 (15%) | 6 (32%) | 3 (15%) | 5 (24%) |
| Condition | |||||
| Arthritis | 32 (34%) | 5 (15%) | 0 | 12 (60%) | 15 (71%) |
| Depression | 17 (18%) | 12 (36%) | 1 (5%) | 4 (20%) | 0 |
| Diabetes | 26 (28%) | 5 (15%) | 18 (95%) | 0 | 3 (14%) |
| Other chronic condition | 13 (14%) | 6 (18%) | 0 | 4 (20%) | 3 (14%) |
| Healthy control or survey | 5 (5%) | 5 (15%) | 0 | 0 | 0 |
| Number of trials (including current one) | |||||
| 1 | 22 (24%) | 1 (3%) | 12 (63%) | 3 (15%) | 6 (29%) |
| 2 | 9 (10%) | 2 (6%) | 4 (21%) | 1 (5%) | 2 (10%) |
| 3 or more | 34 (37%) | 17 (52%) | 2 (11%) | 6 (30%) | 9 (43%) |
| Unknown | 28 (30%) | 13 (39%) | 1 (5%) | 10 (50%) | 4 (19%) |